Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.
about
To Revascularise or Not To Revascularise, That Is the Question: the Diagnostic and Management Conundrum of Ischaemic CardiomyopathyMyocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass graftingFractional flow reserve-guided percutaneous coronary intervention is not a valid concept.Exercise capacity and mortality in patients with ischemic left ventricular dysfunction randomized to coronary artery bypass graft surgery or medical therapy: an analysis from the STICH trial (Surgical Treatment for Ischemic Heart Failure).Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].Japan Implantable Devices in Coronary Artery Disease (JID-CAD) study design.Noninvasive assessment myocardial viability: current status and future directions.DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4.Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.Determinants of outcome in patients with chronic ischemic left ventricular dysfunction undergone percutaneous coronary interventionsIschaemia change with revascularisation versus medical therapy in reduced ejection fraction.Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic CardiomyopathyCardiac CT vs. Stress Testing in Patients with Suspected Coronary Artery Disease: Review and Expert RecommendationsImportance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH.Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA.Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiographyAssessing clinical impact of myocardial perfusion studies: ischemia or other prognostic indicators?New insights from major prospective cohort studies with cardiac nuclear imaging.Advances in SPECT in evaluating coronary disease.The benefits of revascularization in chronic heart failure.Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities?Should extensive myocardial ischaemia prompt revascularization to improve outcomes in chronic coronary artery disease?Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize.Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.Quantitative Coronary Physiology for Clinical Management: the Imaging Standard.Ischemia-guided myocardial revascularization: the oculo-ischemic reflex.Korean Guidelines for Diagnosis and Management of Chronic Heart Failure.Interventional therapies in ischemic ventricular dysfunction: facts and versions!Rethinking Revascularization in Left Ventricular Systolic Dysfunction.The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?Relationship between myocardial perfusion abnormalities and contractile impairment in anginal patients.Six-minute walk distance after coronary artery bypass grafting compared with medical therapy in ischaemic cardiomyopathy.(‑)‑Epicatechin protects against myocardial ischemia‑induced cardiac injury via activation of the PTEN/PI3K/AKT pathway.
P2860
Q26749674-CDA8FB4B-BF64-45D7-8E32-C94FF40A30F3Q27300772-3D7109CD-F1EE-4F14-B0C4-134261A57D8FQ33699147-302CC118-03C9-43C0-8091-22257043C0DAQ34022098-AF7516F3-41DF-4CFC-87FA-8B145800C21BQ34031313-383B255A-C7E9-4D6C-B24C-CB6176D5A36FQ34492324-8BC47CDC-F652-49CA-848E-4414B7803083Q34774619-288C4DF3-0D59-4AB9-A1CE-CE2E7D43CA8AQ35098869-347C7FC3-89EC-431B-9A77-48C5A77A57B4Q35771737-304094D6-0217-4C7A-8F70-289A271D3979Q35822159-D85CDBA8-2767-4427-8F71-61FA632606D2Q36012167-6B1B9C83-B83D-4311-9EB4-7E18E3B07F3EQ36108754-C17FF7B9-D901-43B3-8471-8F086DF6DE89Q36185492-1741D821-EE7A-41D9-A4F2-E74A7CE3BDE8Q36306239-7EB8FD6D-1985-43F4-A15C-082388DF80A7Q37637815-AB11BE46-B6CF-490F-AB82-280D23C0AD8BQ37656578-7A234F80-668B-4D7D-A9EC-8E0812A387D7Q38192512-4F00354C-7FE5-49D4-8A12-64CC555C9DB4Q38197125-A3C7BCE4-2303-4A80-80AA-11409A2A38FFQ38231506-FCDBDDE3-87B2-4EAD-AFA3-854BB9DBD4A5Q38286993-9A213DCD-B6A7-44A4-A4C3-A3D31F1B1F6FQ38441632-BF2EA61E-8691-41BB-9F2B-CEB1FE92EF76Q38529835-C9A2851C-B1A2-4A05-9E17-4E5BB80FFA74Q38589870-6A6AEB96-C748-4886-A825-D19B9661C68CQ38652030-EF98C488-110E-446A-82E2-B53C774CB1A0Q38688829-20BC6F5C-CCCB-4833-8B96-81FDAF7817EEQ39819658-BEA9A505-7901-462B-BD6A-7739B123591DQ41686228-FB78DA02-C4D9-4892-9AF3-74A0A5F6C39DQ42370371-3E477E57-03A3-44BB-A594-75FFE70E8D1AQ47104356-C04C63F6-995B-41B6-A9F0-D0F81B1BCD48Q48613788-57D58DCF-836C-4966-B250-0FD74E7E755BQ48841088-E3936129-3C3A-4514-B5A4-0F6E768FA8DDQ52659263-37245E20-31B5-496B-B295-38722AAE244BQ54961425-D3C22F42-A63B-4A15-98A8-80DBADAAAEB4
P2860
Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inducible myocardial ischemia ...... left ventricular dysfunction.
@en
Inducible myocardial ischemia ...... left ventricular dysfunction.
@nl
type
label
Inducible myocardial ischemia ...... left ventricular dysfunction.
@en
Inducible myocardial ischemia ...... left ventricular dysfunction.
@nl
prefLabel
Inducible myocardial ischemia ...... left ventricular dysfunction.
@en
Inducible myocardial ischemia ...... left ventricular dysfunction.
@nl
P2093
P2860
P1476
Inducible myocardial ischemia ...... left ventricular dysfunction.
@en
P2093
Daniel S Berman
Eric J Velazquez
Federico M Asch
Julio A Panza
Kerry L Lee
Patricia A Pellikka
Pedro S Farsky
Robert H Jones
Robert O Bonow
P2860
P304
P356
10.1016/J.JACC.2013.02.014
P407
P577
2013-03-07T00:00:00Z